MCM10 and cancer: To investigate the potential of Mcm10 inhibitors to preferentially kill cancer cells, the effect of suramin, NF157 (the most potent suramin analogue), NF546 (lower affinity, but higher selectivity), iso-PPADS and PPADS (low affinity, but most selective) on the survival of two cell lines of epithelial origin was tested.